Apolipoprotein E polymorphism in Alzheimer's disease: A comparative study of two research populations from Spain and the United States

European Neurology

Volumn 39, Issue 4, 1998, Pages 229-233

  Lopez, Oscar L ^a,d   Lopez Pousa, Secundino ^c   Kamboh, M Ilyas ^a,b   Adroer, Rosa ^c   Oliva, Rafael ^c   Lozano Gallego, Manuela ^c   Becker, James T ^a   DeKosky, Steven T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c HOSPITAL SANTA CATERINA   (Spain)

^d Neuropsychological Research Program   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia

Indexed keywords

APOLIPOPROTEIN E; DNA;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SPAIN; UNITED STATES;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; RESEARCH DESIGN; RISK FACTORS; SPAIN; UNITED STATES;

EID: 0031971279     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007939     Document Type: Article

References (32)

1. Gerdes LU, Klausen IC, Sihm I, Faergeman O: Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Gen Epidemiol 1992;9:155-167.
2. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G: Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-235.
3. Stengard JH, Pekkamen J, Ehnholm C, Nissinen, Sing CF: Genotypes with the apolipoprotein epsilon 4 allele are predictors of coronary heart disease and mortality in a longitudinal study of elderly Finnish men. Hum Genet 1996;97:677-684.
4. James RW, Boemi M, Giansanti R, Fumelli P, Pometta D: Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscl Thromb 1993;13:1456-1459.
5. Muros M, Rodriguez-Ferrer C: Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population under expressing apo E4. Atherosclerosis 1996; 121:13-21.
6. Carioulou MA, Kokkofitou A, Manoli P, Chritou S, Karagrigorou A, Middleton L: Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus. Gen Epidemiol 1995;12:489-497.
7. Kamboh MI, Aston CE, Hamman RF: The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a bi-ethnic population from the San Luis Valley, Colorado. Atherosclerosis 1995; 115:145-159.
8. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeaux R: Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 1996;58: 574-584.
9. Myers RH, Schaefer EJ, Wilson PWF, D'Agostino R, Ordovas JM, Espino A, White RF, Cobb JL, McNulty KA, Beiser A, Wolf PA: Apolipoprotein E4 association with dementia in a population-based study: The Framingham study. Neurology 1996;46:673-677.
10. Hendrie HC, Hall KS, Hui S, Unverzagt FW, Yu CE, Lahiri DK, Sahota A, Farlow M, Musick B, Class CA, Brashear A, Burdine VE, Osuntokum BO, Ogunniyi AO, Gureje O, Baiyewu O, Schellenberg GD: Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-120.
11. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High avidity binding to beta-amyloid and increase frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
12. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347:1091-1095.
13. Tsuang D, Kukull W, Sheppard L, Barnhart RL, Peskind E, Edland SD, Schellenberg G, Raskind M, Larson EB: A comparison of two Alzheimer's disease samples. J Am Geriatr Soc 1996;44:704-707.
14. Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amaducci L: APOE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 1994;177:100-102.
15. Adroer R, Santacruz P, Blesa R, Lopez-Pousa S, Ascaso C, Oliva R: Apolipoprotein E4 allele in Spanish Alzheimer and control cases. Neurosci Lett 1995;189:1-5.
16. Tang MX, Stern Y, Shofield P, Tycko B, Mayeux R: Incidence of Alzheimer's disease by APOE genotype among elderly African-A, Caucasians, and Hispanics in New York City. Neurology 1997 (suppl 3):A54.
17. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlam EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
18. Lopez-Pousa S, Llinas-Regla J, Vilalta-Franch, Lozano-Fernandez de Pinedo R: The prevalence of dementia in Girona. Neurología 1995; 10:189-193.
19. Lobo A, Día LL: Screening del deterioro cognitivo. Phronesis 1986;7:158-165.
20. Llinás-Regla J, Lopez-Pousa S, Vilalta-Franch J: The efficiency of CAMDEX in the diagnosis of dementia and its sub-types. Neurología 1995;10:133-138.
21. Roth M, Huppert FA, Tym E, Mountjoy CQ: CAMDEX. The Cambridge Examination for Mental Disorders of the Elderly. Cambridge, Cambridge University Press, 1988.
22. Becker JT, Boller F, Lopez OL, Saxton J, McGonigle K: The natural history of Alzheimer's disease. Arch Neurol 1994;51:585-594.
23. Lopez OL, Gonzalez MP, Becker JT, Reynolds CF, Sudilovsky A, DeKosky ST: Symptoms of depression and psychosis in Alzheimer's disease and frontotemporal dementia: Exploration of underlying mechanisms. Neuropsychiatry Neuropsychol Behav Neurol 1996;9:154-161.
24. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-198.
25. Mattis S: Mental status examination for organic mental syndrome in the elderly patient; in Bellak L, Karasu TB (eds): Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. New York, Grune & Stratton, 1976, pp 77-121.
26. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST: APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet 1995;10:486-488.
27. US Census Bureau, 1990.
28. Generalitat de Catalunya. Característiques de la poblacío; in Plan de la Salut de Catalunya. Barcelona, YAN, Ediciones I Creaciones Gràfiques, 1993, pp 27-59.
29. Folstein ME, Anthony JC, Parhad I, Duffy B, Gruenberg EM: The meaning of cognitive impairment in the elderly. J Am Geriatr Soc 1985; 33:228-235.
30. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO: Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989;262:2551-2556.
31. Lopez-Pousa S: Epidemiología de las demencias: in Lopez-Pousa S (ed): Actualización en Demencias. Barcelona, Prous, 1995, pp 1-12.
32. Webster's Ninth New Collegiate Dictionary. Springfield, Mass., Merriam-Webster, 1991.